Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to evaluate whether patients who benefit from a personalized pharmaceutical plan (PPP) during their hospitalization, allowing them to be informed and sensitized, are treated for a shorter period of time with strong opioids with a reduced risk of dependence compared to a management according to the usual modalities in the rheumatology services concerned.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05905146
Study type Interventional
Source University Hospital, Rouen
Contact Catherine CHENAILLER
Phone +3323288
Email catherine.chenailler@chu-rouen.fr
Status Not yet recruiting
Phase N/A
Start date September 15, 2023
Completion date March 15, 2026